• FirefoxInstall the new Firefox »
  •  Dow Down 0.58% Nasdaq Down 0.26%

    Apricus Biosciences, Inc. (APRI)

    -NasdaqCM
    2.50 Up 0.11(4.60%) 4:00PM EST
    |After Hours : 2.49 Down 0.01 (0.40%) 4:26PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.39
    Open:2.34
    Bid:2.31 x 300
    Ask:2.53 x 300
    1y Target Est:5.10
    Beta:2.32
    Earnings Date:Mar 16 - Mar 20 (Est.)
    Day's Range:2.30 - 2.52
    52wk Range:0.92 - 2.75
    Volume:443,142
    Avg Vol (3m):447,333
    Market Cap:109.06M
    P/E (ttm):N/A
    EPS (ttm):-0.15
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for APRI

    Comparison

    Symbol% ChgMkt Cap
    APRIUp 4.60%109.06M
    ADMPUp 3.67%74.60M
    PFEUp 0.23%212.30B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):13.52
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.23
    Quarterly EPS Est (Dec-14) :-0.12
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Apricus Biosciences, Inc. is a biopharmaceutical company advancing medicines in urology and rheumatology. Its lead product, Vitaros, for the treatment of erectile dysfunction, is approved in Europe and Canada and is being commercialized in various... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback